AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month […]
More Stories
Comstock Holding Companies (NASDAQ:CHCI) Announces Quarterly Earnings Results
Comstock Holding Companies (NASDAQ:CHCI – Get Free Report) posted its earnings results on Monday. The construction company reported $0.15 earnings...
Is 2025 Your Year For Investing?
cIf you are thinking about doing something useful with your money, hopefully with a view to making it grow, there...
Should You Have Your Kids Play Indoors or Outdoors? These Are the Pros and Cons
Children should be given every opportunity to play. They need to use this time to explore and learn more about...
Is This the End for Ram’s Most Affordable Pickup Truck?
After years of loyal service, you might be saddened to hear that the Ram 1500 Classic is finally being put...
The Manufacturers Life Insurance Company Sells 2,680 Shares of Resideo Technologies, Inc. (NYSE:REZI)
The Manufacturers Life Insurance Company lessened its holdings in shares of Resideo Technologies, Inc. (NYSE:REZI – Free Report) by 3.4%...
Core Scientific, Inc. (NASDAQ:CORZ) Shares Sold by The Manufacturers Life Insurance Company
The Manufacturers Life Insurance Company trimmed its holdings in shares of Core Scientific, Inc. (NASDAQ:CORZ – Free Report) by 3.0%...